Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2013 (2013), Article ID 141083, 6 pages
http://dx.doi.org/10.1155/2013/141083
Review Article

Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases

Department of Experimental Medical Science, Experimental Dementia Research Unit, Wallenberg Neuroscience Center, Lund University, 221 84 Lund, Sweden

Received 17 May 2013; Accepted 23 September 2013

Academic Editor: Alessio Cardinale

Copyright © 2013 Gunnar K. Gouras. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Mucke and D. J. Selkoe, “Neurotoxicity of amyloid β-protein: synaptic and network dysfunction,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 7, Article ID a006338, 2012. View at Publisher · View at Google Scholar
  2. G. K. Gouras, D. Tampellini, R. H. Takahashi, and E. Capetillo-Zarate, “Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease,” Acta Neuropathologica, vol. 119, no. 5, pp. 523–541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Bellucci, M. Zaltieri, L. Navarria, J. Grigoletto, C. Missale, and P. Spano, “From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease,” Brain Research, vol. 1476, pp. 183–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Stefanis, “α-Synuclein in Parkinson's disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 2, Article ID 009399, 2012. View at Publisher · View at Google Scholar
  5. C. Haass, C. Kaether, G. Thinakaran G, and S. Sisodia, “Trafficking and proteolytic processing of APP,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 5, Article ID 006270, 2012. View at Publisher · View at Google Scholar
  6. J. J. Lah, C. J. Heilman, N. R. Nash et al., “Light and electron microscopic localization of presenilin-1 in primate brain,” The Journal of Neuroscience, vol. 17, no. 6, pp. 1971–1980, 1997. View at Google Scholar · View at Scopus
  7. H. Zheng, M. Jiang, M. E. Trumbauer et al., “β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity,” Cell, vol. 81, no. 4, pp. 525–531, 1995. View at Google Scholar · View at Scopus
  8. R. Chiesa and D. A. Harris, “Fishing for prion protein function,” PLoS Biology, vol. 7, no. 3, pp. 0439–0443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Kamenetz, T. Tomita, H. Hsieh et al., “APP processing and synaptic function,” Neuron, vol. 37, no. 6, pp. 925–937, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Tampellini, N. Rahman, E. F. Gallo et al., “Synaptic activity reduces intraneuronal Aβ, promotes APP transport to synapses, and protects against Aβ-related synaptic alterations,” The Journal of Neuroscience, vol. 29, no. 31, pp. 9704–9713, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Tampellini, E. Capetillo-Zarate, M. Dumont et al., “Effects of synaptic modulation on β-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice,” The Journal of Neuroscience, vol. 30, no. 43, pp. 14299–14304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ihara, M. Morishima-Kawashima, and R. Nixon, “The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 8, 2012. View at Publisher · View at Google Scholar
  13. M. D. Ehlers, “Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system,” Nature Neuroscience, vol. 6, no. 3, pp. 231–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. B. A. Bahr and J. Bendiske, “The neuropathogenic contributions of lysosomal dysfunction,” Journal of Neurochemistry, vol. 83, no. 3, pp. 481–489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Cataldo, C. M. Peterhoff, J. C. Troncoso, T. Gomez-Isla, B. T. Hyman, and R. A. Nixon, “Endocytic pathway abnormalities precede amyloid β deposition in sporadic alzheimer's disease and down syndrome: differential effects of APOE genotype and presenilin mutations,” American Journal of Pathology, vol. 157, no. 1, pp. 277–286, 2000. View at Google Scholar · View at Scopus
  16. R. A. Nixon, “Autophagy in neurodegenerative disease: friend, foe or turncoat?” Trends in Neurosciences, vol. 29, no. 9, pp. 528–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. E. Harrison, R. Strong, Z. D. Sharp et al., “Rapamycin fed late in life extends lifespan in genetically heterogeneous mice,” Nature, vol. 460, no. 7253, pp. 392–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo, “Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau: effects on cognitive impairments,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 13107–13120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Spilman, N. Podlutskaya, M. J. Hart et al., “Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of alzheimer's disease,” PLoS ONE, vol. 5, no. 4, Article ID e9979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Ma, C. A. Hoeffer, E. Capetillo-Zarate et al., “Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease,” PLoS ONE, vol. 5, no. 9, Article ID e12845, pp. 1–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Park, E. C. Penick, J. G. Edwards, J. A. Kauer, and M. D. Ehlers, “Recycling endosomes supply AMPA receptors for LTP,” Science, vol. 305, no. 5692, pp. 1972–1975, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Rajendran and W. Annaert, “Membrane trafficking pathways in Alzheimer's disease,” Traffic, vol. 13, no. 6, pp. 759–770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. H. Takahashi, T. A. Milner, F. Li et al., “Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology,” American Journal of Pathology, vol. 161, no. 5, pp. 1869–1879, 2002. View at Google Scholar · View at Scopus
  24. R. H. Takahashi, C. G. Almeida, P. F. Kearney et al., “Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain,” The Journal of Neuroscience, vol. 24, no. 14, pp. 3592–3599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Capetillo-Zarate, L. Gracia, F. Yu et al., “High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils,” American Journal of Pathology, vol. 179, no. 5, pp. 2551–2558, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. C. G. Almeida, R. H. Takahashi, and G. K. Gouras, “β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system,” The Journal of Neuroscience, vol. 26, no. 16, pp. 4277–4288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Skibinski, N. J. Parkinson, J. M. Brown et al., “Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia,” Nature Genetics, vol. 37, no. 8, pp. 806–808, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Pooler, E. C. Phillips, D. H. Lau, W. Noble, and D. P. Hanger, “Physiological release of endogenous tau is stimulated by neuronal activity,” EMBO Reports, vol. 14, no. 4, pp. 389–394, 2013. View at Publisher · View at Google Scholar
  29. B. Frost and M. I. Diamond, “Prion-like mechanisms in neurodegenerative diseases,” Nature Reviews Neuroscience, vol. 11, no. 3, pp. 155–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-C. Cossec, C. Marquer, M. Panchal, A. N. Lazar, C. Duyckaerts, and M.-C. Potier, “Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes,” Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 839–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Grösgen, M. O. W. Grimm, P. Frieß, and T. Hartmann, “Role of amyloid beta in lipid homeostasis,” Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 966–974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Hedskog, C. M. Pinho, R. Filadi et al., “Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 19, pp. 7916–7921, 2013. View at Publisher · View at Google Scholar
  33. J. Li, T. Kanekiyo, M. Shinohara et al., “Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms,” Journal of Biological Chemistry, vol. 287, no. 53, pp. 44593–44601, 2012. View at Publisher · View at Google Scholar
  34. M. A. Kuszczyk, S. Sanchez, J. Pankiewicz et al., “Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration,” American Journal of Pathology, vol. 182, no. 5, pp. 1750–1768, 2013. View at Publisher · View at Google Scholar
  35. L. Melman, H. J. Geuze, Y. Li et al., “Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway,” Molecular Biology of the Cell, vol. 13, no. 9, pp. 3325–3335, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. W.-Q. Zou and N. R. Cashman, “Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form,” Journal of Biological Chemistry, vol. 277, no. 46, pp. 43942–43947, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. Gorman, C. M. Yip, P. E. Fraser, and A. Chakrabartty, “Alternate aggregation pathways of the Alzheimer β-amyloid peptide: Aβ association kinetics at endosomal pH,” Journal of Molecular Biology, vol. 325, no. 4, pp. 743–757, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. W. B. Stine Jr., K. N. Dahlgren, G. A. Krafft, and M. J. LaDu, “In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis,” Journal of Biological Chemistry, vol. 278, no. 13, pp. 11612–11622, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Y. Yang, D. Chandswangbhuvana, L. Margol, and C. G. Glabe, “Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis,” Journal of Neuroscience Research, vol. 52, pp. 691–698, 1998. View at Publisher · View at Google Scholar
  40. K. Ditaranto, T. L. Tekirian, and A. J. Yang, “Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease,” Neurobiology of Disease, vol. 8, no. 1, pp. 19–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. S. B. Prusiner, “Cell biology. A unifying role for prions in neurodegenerative diseases,” Science, vol. 336, no. 6088, pp. 1511–1513, 2012. View at Publisher · View at Google Scholar
  42. G. Suzuki, N. Shimazu, and M. Tanaka, “A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress,” Science, vol. 336, no. 6079, pp. 355–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. R. B. Wickner, H. K. Edskes, D. Kryndushkin, R. McGlinchey, D. Bateman, and A. Kelly, “Prion diseases of yeast: amyloid structure and biology,” Seminars in Cell and Developmental Biology, vol. 22, no. 5, pp. 469–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. D. M. Fowler, A. V. Koulov, W. E. Balch, and J. W. Kelly, “Functional amyloid—from bacteria to humans,” Trends in Biochemical Sciences, vol. 32, no. 5, pp. 217–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. D. Steele, S. Lindquist, and A. Aguzzi, “The prion protein knockout mouse: a phenotype under challenge,” Prion, vol. 1, no. 2, pp. 83–93, 2007. View at Google Scholar · View at Scopus
  46. M. Jucker and L. C. Walker, “Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders,” Annals of Neurology, vol. 70, no. 4, pp. 532–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Stohr, J. C. Watts, Z. L. Mensinger et al., “Purified and synthetic Alzheimer's amyloid beta (Aβ) prions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 27, pp. 11025–11030, 2012. View at Publisher · View at Google Scholar
  48. J.-Y. Li, E. Englund, J. L. Holton et al., “Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation,” Nature Medicine, vol. 14, no. 5, pp. 501–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. K. C. Luk, V. Kehm, J. Carroll et al., “Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice,” Science, vol. 338, no. 6109, pp. 949–953, 2012. View at Publisher · View at Google Scholar
  50. A. J. Yang, D. Chandswangbhuvana, T. Shu, A. Henschen, and C. G. Glabe, “Intracellular accumulation of insoluble, newly synthesized Aβn-42 in amyloid precursor protein-transfected cells that have been treated with Aβ1- 42,” Journal of Biological Chemistry, vol. 274, no. 29, pp. 20650–20656, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Brandner, S. Isenmann, A. Raeber et al., “Normal host prion protein necessary for scrapie-induced neurotoxicity,” Nature, vol. 379, no. 6563, pp. 339–343, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Mallucci, A. Dickinson, J. Linehan, P.-C. Klöhn, S. Brandner, and J. Collinge, “Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis,” Science, vol. 302, no. 5646, pp. 871–874, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Saavedra, A. Mohamed, V. Ma, S. Kar, and E. P. De Chaves, “Internalization of β-amyloid peptide by primary neurons in the absence of apolipoprotein E,” Journal of Biological Chemistry, vol. 282, no. 49, pp. 35722–35732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Nath, L. Agholme, F. R. Kurudenkandy, B. Granseth, J. Marcusson, and M. Hallbeck, “Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid,” The Journal of Neuroscience, vol. 32, no. 26, pp. 8767–8777, 2012. View at Publisher · View at Google Scholar
  55. L. Rajendran, M. Honsho, T. R. Zahn et al., “Alzheimer's disease β-amyloid peptides are released in association with exosomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11172–11177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Tampellini, N. Rahman, M. T. Lin, E. Capetillo-Zarate, and G. K. Gouras, “Impaired β-amyloid secretion in Alzheimer's disease pathogenesis,” The Journal of Neuroscience, vol. 31, no. 43, pp. 15384–15390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. D. J. Irwin, J. Y. Abrams, L. B. Schonberger et al., “Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone,” JAMA Neurology, vol. 70, no. 4, pp. 462–468, 2013. View at Publisher · View at Google Scholar